The nasal spray 'most preferred to be prescribed' was TAA (38.2%), followed by FP (36.8%) and MF (24.9%). Furthermore, 82.3% of the patients indicated that they would 'definitely comply' with a ...
Nasonex aqueous nasal spray) 200µg triamcinolone acetonide aqueous (TAA, Nasacort aqueous nasal spray) 220µg A multicentre, double-blind, crossover, comparative, randomised study design was used.